233 related articles for article (PubMed ID: 15103509)
1. Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances.
Leblond V; Tournilhac O; Morel P
Clin Exp Med; 2004 Apr; 3(4):187-98. PubMed ID: 15103509
[TBL] [Abstract][Full Text] [Related]
2. Waldenström's macroglobulinemia.
Dimopoulos MA; Anagnostopoulos A
Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
[TBL] [Abstract][Full Text] [Related]
3. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of Waldenstrom's macroglobulinemia.
Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
Anagnostopoulos A; Giralt S
Bone Marrow Transplant; 2002 Jun; 29(12):943-7. PubMed ID: 12098060
[TBL] [Abstract][Full Text] [Related]
6. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
7. Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center.
Merchionne F; Procaccio P; Dammacco F
Crit Rev Oncol Hematol; 2011 Oct; 80(1):87-99. PubMed ID: 21036057
[TBL] [Abstract][Full Text] [Related]
8. Advanced Waldenström's macroglobulinemia: usefulness of Morel's scoring system in establishing prognosis.
Lévy V; Morel P; Porcher R; Chevret S; Wattel E; Leblond V
Haematologica; 2005 Feb; 90(2):279-81. PubMed ID: 15710594
[TBL] [Abstract][Full Text] [Related]
9. Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions.
Anagnostopoulos A; Aleman A; Giralt S
Semin Oncol; 2003 Apr; 30(2):286-90. PubMed ID: 12720154
[TBL] [Abstract][Full Text] [Related]
10. Waldenstrom's macroglobulinemia.
Singhal N; Bapsy PP; Babu KG; Sahoo TP
J Assoc Physicians India; 2004 Dec; 52():981-5. PubMed ID: 15884458
[TBL] [Abstract][Full Text] [Related]
11. Waldenström's macroglobulinaemia: current therapy and future approaches.
Desikan R; Li Z; Jagannath S
BioDrugs; 2002; 16(3):201-7. PubMed ID: 12102647
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine in Waldenstrom's macroglobulinemia.
Leblond V; Choquet S
Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
[TBL] [Abstract][Full Text] [Related]
13. How we treat Waldenström's macroglobulinemia.
Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
Anagnostopoulos A; Dimopoulos MA; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
Bone Marrow Transplant; 2001 May; 27(10):1027-9. PubMed ID: 11438816
[TBL] [Abstract][Full Text] [Related]
15. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
Anagnostopoulos A; Hari PN; Pérez WS; Ballen K; Bashey A; Bredeson CN; Freytes CO; Gale RP; Gertz MA; Gibson J; Goldschmidt H; Lazarus HM; McCarthy PL; Reece DE; Vesole DH; Giralt SA
Biol Blood Marrow Transplant; 2006 Aug; 12(8):845-54. PubMed ID: 16864055
[TBL] [Abstract][Full Text] [Related]
16. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia.
Martino R; Shah A; Romero P; Brunet S; Sierra J; Domingo-Albós A; Fruchtman S; Isola L
Bone Marrow Transplant; 1999 Apr; 23(7):747-9. PubMed ID: 10218857
[TBL] [Abstract][Full Text] [Related]
18. Current and future therapeutic approach for Waldenström's macroglobulinemia.
Souchet-Cömpain L; Choquet S; Leblond V; Nguyen S
Immunotherapy; 2014; 6(3):333-48. PubMed ID: 24762077
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of Waldenström's macroglobulinemia.
Johnson SA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):329-34. PubMed ID: 16503850
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine in Waldenstrom's macroglobulinemia.
Souchet-Compain L; Nguyen S; Choquet S; Leblond V
Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
